Swaminathan; Sundaramoorthi
Patent Applications and Registrations
Patent applications and USPTO patent grants for Swaminathan; Sundaramoorthi.The latest application filed is for "substituted 6-azabenzimidazole compounds".
Company Profile
5.25.40
- Swaminathan; Sundaramoorthi - Burlingame CA
Patent Activity
| Patent | Date |
|---|---|
| Substituted 6-azabenzimidazole Compounds App 20220213091 - Balan; Gayatri ; et al. | 2022-07-07 |
| Substituted 6-azabenzimidazole compounds Grant 11,203,591 - Balan , et al. December 21, 2 | 2021-12-21 |
| Substituted 6-azabenzimidazole Compounds App 20210115037 - Balan; Gayatri ; et al. | 2021-04-22 |
| CRYSTALLINE MONOMESYLATE SALT OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZ- O[1,2-a]PYRAZIN-8-AMINE App 20210060011 - Blomgren; Peter A. ; et al. | 2021-03-04 |
| Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidaz- o[1,2-a]pyrazin-8-amine Grant 10,828,299 - Blomgren , et al. November 10, 2 | 2020-11-10 |
| Syk Inhibitors App 20190388419 - Blomgren; Peter A. ; et al. | 2019-12-26 |
| Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Grant 10,342,794 - Blomgren , et al. July 9, 2 | 2019-07-09 |
| Syk Inhibitors App 20180325896 - Blomgren; Peter A. ; et al. | 2018-11-15 |
| Syk Inhibitors App 20180280387 - Blomgren; Peter A. ; et al. | 2018-10-04 |
| Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Grant 9,968,601 - Blomgren , et al. May 15, 2 | 2018-05-15 |
| Syk inhibitors Grant 9,931,338 - Blomgren , et al. April 3, 2 | 2018-04-03 |
| Syk Inhibitors App 20170035755 - BLOMGREN; PETER A. ; et al. | 2017-02-09 |
| Syk inhibitors Grant 9,504,684 - Blomgren , et al. November 29, 2 | 2016-11-29 |
| Syk Inhibitors App 20160310490 - Blomgren; Peter A. ; et al. | 2016-10-27 |
| Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Grant 9,290,505 - Blomgren , et al. March 22, 2 | 2016-03-22 |
| Syk Inhibitors App 20160058758 - Blomgren; Peter A. ; et al. | 2016-03-03 |
| Antiviral phosphonate analogs Grant 9,139,604 - Boojamra , et al. September 22, 2 | 2015-09-22 |
| Antiviral Phosphonate Analogs App 20150025039 - BOOJAMRA; Constantine G. ; et al. | 2015-01-22 |
| Antiviral phosphonate analogs Grant 8,022,083 - Boojamra , et al. September 20, 2 | 2011-09-20 |
| Methods Of Treating Hbv And Hcv Infection App 20110150836 - HALCOMB; Randall L. ; et al. | 2011-06-23 |
| Nucleoside Phosphonate Analogs App 20110071101 - Boojamra; Constantine G. ; et al. | 2011-03-24 |
| Phosphonate inhibitors of HCV Grant 7,842,672 - Boojamra , et al. November 30, 2 | 2010-11-30 |
| AZA-peptide protease inhibitors Grant 7,741,345 - Cannizzaro , et al. June 22, 2 | 2010-06-22 |
| Antiviral protease inhibitors Grant 7,723,380 - Cannizzaro , et al. May 25, 2 | 2010-05-25 |
| Monophosphates as Mutual Prodrugs of Muscarinic Receptor Antagonists and Beta-Agonists for the Treatment of COPD And Chronic Bronchitis App 20100112061 - Baker; William ; et al. | 2010-05-06 |
| Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction App 20100098641 - Baker; William ; et al. | 2010-04-22 |
| Anti-cancer Phosphonate Analogs App 20100022467 - Boojamra; Constantine G. ; et al. | 2010-01-28 |
| Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds Grant 7,649,015 - Arimili , et al. January 19, 2 | 2010-01-19 |
| Therapeutic phosphonate compounds Grant 7,645,747 - Boojamra , et al. January 12, 2 | 2010-01-12 |
| Therapeutic Compounds And Methods App 20090312318 - Desai; Manoj C. ; et al. | 2009-12-17 |
| Antiviral Protease Inhibitors App 20090306112 - Cannizzaro; Carina E. ; et al. | 2009-12-10 |
| Antiviral Phosphonate Analogs App 20090275535 - Boojamra; Constantine G. ; et al. | 2009-11-05 |
| Anti-inflammatory Phosphonate Compounds App 20090247488 - Cannizzaro; Carina ; et al. | 2009-10-01 |
| Phosphonate Compounds Having Immuno-modulatory Activity App 20090227543 - Cannizzaro; Carina ; et al. | 2009-09-10 |
| Kinase Inhibitory Phosphonate Analogs App 20090181930 - Cannizzaro; Carina ; et al. | 2009-07-16 |
| Antiviral protease inhibitors App 20090105279 - Cannizzaro; Carina E. ; et al. | 2009-04-23 |
| AZA-peptide protease inhibitors App 20090099096 - Cannizzaro; Carina E. ; et al. | 2009-04-16 |
| Phosphonate compounds having immuno-modulatory activity Grant 7,470,724 - Cannizzaro , et al. December 30, 2 | 2008-12-30 |
| Anti-cancer phosphonate analogs Grant 7,452,901 - Boojamra , et al. November 18, 2 | 2008-11-18 |
| Anti-inflammatory phosphonate compounds Grant 7,432,261 - Cannizzaro , et al. October 7, 2 | 2008-10-07 |
| Antiviral phosphonate analogs Grant 7,429,565 - Boojamra , et al. September 30, 2 | 2008-09-30 |
| Purine nucleoside phosphorylase inhibitory phosphonate compounds Grant 7,427,624 - Chen , et al. September 23, 2 | 2008-09-23 |
| Kinase inhibitory phosphonate analogs Grant 7,417,055 - Cannizzaro , et al. August 26, 2 | 2008-08-26 |
| Phosphonate inhibitors of HCV App 20080107628 - Boojamra; Constantine G. ; et al. | 2008-05-08 |
| Therapeutic compounds and methods App 20080070910 - Desai; Manoj C. ; et al. | 2008-03-20 |
| Method and compositions for identifying anti-hiv therapeutic compounds App 20070190523 - Birkus; Gabriel ; et al. | 2007-08-16 |
| Purine nucleoside phosphorylase inhibitory phosphonate compounds App 20070027113 - Chen; James ; et al. | 2007-02-01 |
| Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds App 20070010489 - Arimilli; Murty N. ; et al. | 2007-01-11 |
| Therapeutic phosphonate compounds App 20060264404 - Boojamra; Constantine G. ; et al. | 2006-11-23 |
| Anti-inflammatory phosphonate compounds App 20060199788 - Cannizzaro; Carina ; et al. | 2006-09-07 |
| Method and compositions for identifying anti-hiv therapeutic compounds App 20060115815 - Birkus; Gabriel ; et al. | 2006-06-01 |
| Anti-cancer phosphonate analogs App 20060079478 - Boojamra; Constantine G. ; et al. | 2006-04-13 |
| Phosphonate compounds having immuno-modulatory activity App 20060035866 - Cannizzaro; Carina ; et al. | 2006-02-16 |
| Kinase inhibitory phosphonate analogs App 20050261253 - Cannizzaro, Carina ; et al. | 2005-11-24 |
| Nucleoside phosphonate analogs App 20050261237 - Boojamra, Constantine G. ; et al. | 2005-11-24 |
| Method and compositions for identifying anti-HIV therapeutic compounds App 20050239054 - Arimilli, Murty N. ; et al. | 2005-10-27 |
| Antiviral phosphonate analogs App 20050215513 - Boojamra, Constantine G. ; et al. | 2005-09-29 |
| Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds App 20050209197 - Arimilli, Murty N. ; et al. | 2005-09-22 |
| Method and compositions for identifying anti-HIV therapeutic compounds App 20040121316 - Birkus, Gabriel ; et al. | 2004-06-24 |
| Modified internucleoside linkages (ii) Grant 6,683,166 - Swaminathan , et al. January 27, 2 | 2004-01-27 |
| Modified internucleoside linkages (ii) App 20030120050 - Swaminathan, Sundaramoorthi ; et al. | 2003-06-26 |
| Modified internucleoside linkages (II) Grant 6,410,702 - Swaminathan , et al. June 25, 2 | 2002-06-25 |
| Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors Grant 5,958,973 - Bischofberger , et al. September 28, 1 | 1999-09-28 |
| Modified internucleoside linkages (II) Grant 5,817,781 - Swaminathan , et al. October 6, 1 | 1998-10-06 |
| Nuclease stable and binding competent oligomers and methods for their use Grant 5,792,608 - Swaminathan , et al. August 11, 1 | 1998-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 